Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
The organization of the sphingosine 1-phosphate signaling system.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Incomplete Septal Cirrhosis After High -Dose Methylprednisolone Therapy And Regression Of Liver Injury.
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.
Pathology of multiple sclerosis: where do we stand?
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Disease mechanisms in MS: RNA profiling uncovers two distinct subsets of patients with multiple sclerosis.
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review.
Age and the role of restricted activities in adjustment to disability related pain.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Multiple sclerosis eye-brain dynamic correlation.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
2015 Multiple Sclerosis Experts Summit.
Multiple sclerosis.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Effect of autoimmune diseases on risk and survival in female cancers.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Pages
« first
‹ previous
…
308
309
310
311
312
313
314
315
316
…
next ›
last »